Misuse of the Well-Stirred Model of Hepatic Drug Clearance: Fig. 1.
Open Access
- 26 February 2007
- journal article
- Published by American Society for Pharmacology & Experimental Therapeutics (ASPET) in Drug Metabolism and Disposition
- Vol. 35 (3), 501-502
- https://doi.org/10.1124/dmd.106.013359
Abstract
No abstract availableThis publication has 13 references indexed in Scilit:
- In Vivo use of the P450 inactivator 1-aminobenzotriazole in the rat: Varied dosing route to elucidate gut and liver contributions to first-pass and systemic clearanceJournal of Pharmaceutical Sciences, 2006
- PHARMACOKINETICS OF ATORVASTATIN AND ITS HYDROXY METABOLITES IN RATS AND THE EFFECTS OF CONCOMITANT RIFAMPICIN SINGLE DOSES: RELEVANCE OF FIRST-PASS EFFECT FROM HEPATIC UPTAKE TRANSPORTERS, AND INTESTINAL AND HEPATIC METABOLISMDrug Metabolism and Disposition, 2006
- Predictions of the In Vivo Clearance of Drugs from Rate of Loss Using Human Liver Microsomes for Phase I and Phase II BiotransformationsPharmaceutical Research, 2006
- EMPIRICAL VALIDATION OF A RAT IN VITRO ORGAN SLICE MODEL AS A TOOL FOR IN VIVO CLEARANCE PREDICTIONDrug Metabolism and Disposition, 2006
- Comparison of clearance predictions using primary cultures and suspensions of human hepatocytesXenobiotica, 2005
- Impact of serum on clearance predictions obtained from suspensions and primary cultures of rat hepatocytesEuropean Journal of Pharmaceutical Sciences, 2004
- IMPACT OF INCUBATION CONDITIONS ON BUFURALOL HUMAN CLEARANCE PREDICTIONS: ENZYME LABILITY AND NONSPECIFIC BINDINGDrug Metabolism and Disposition, 2004
- Basic anatomical and physiological data for use in radiological protection: reference valuesAnnals of the ICRP, 2002
- Clearance concepts in pharmacokineticsJournal of Pharmacokinetics and Biopharmaceutics, 1973
- FACTORS AFFECTING DRUG METABOLISMAnnals of the New York Academy of Sciences, 1971